Andrew L. Finn,Pharm.D
2012
In 2012, Andrew L. Finn,Pharm.D earned a total compensation of $495.1K as Executive VP of Product Development at BioDelivery Sciences International.
Compensation breakdown
| Bonus | $87,900 |
|---|---|
| Option Awards | $73,684 |
| Salary | $296,785 |
| Other | $36,755 |
| Total | $495,124 |
FinnPharmD received $296.8K in salary, accounting for 60% of the total pay in 2012.
FinnPharmD also received $87.9K in bonus, $73.7K in option awards and $36.8K in other compensation.
Rankings
In 2012, Andrew L. Finn,Pharm.D's compensation ranked 8,794th out of 11,487 executives tracked by ExecPay. In other words, FinnPharmD earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,794 out of 11,487 | 23rd |
Division Manufacturing | 3,206 out of 4,253 | 25th |
Major group Chemicals And Allied Products | 865 out of 1,198 | 28th |
Industry group Drugs | 636 out of 920 | 31st |
Industry Pharmaceutical Preparations | 492 out of 700 | 30th |
Source: SEC filing on June 5, 2015.
FinnPharmD's colleagues
We found four more compensation records of executives who worked with Andrew L. Finn,Pharm.D at BioDelivery Sciences International in 2012.
2012
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
2012
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
2012
James McNulty
BioDelivery Sciences International
Chief Financial Officer
2012
Andrew Finn
BioDelivery Sciences International